HopeStage
Back to all studies
CompletedNCT06466655

Daily stress, blood vessel function and memory health in midlife

About this titleRead the official source — NCT06466655
Medication studyAges 40–55United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 40 years to 55 years.

Listed locations
NewarkSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 30, 2024
Recruitment status
Completed
Enrollment listed in the registry
17
Sponsor
University of Delaware
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 40 Years to 55 Years
Official registry ID
NCT06466655
Official title
Show the full official title

Accelerated Vascular Aging in Midlife as a Mechanism Linking Daily Stress to Cognitive Decline

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Newark

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Delaware, a university.

Did this study involve medication?

Yes. The study involved medication, including MitoTempol and Lactated Ringer's (control).

Who was this study for?

Listed age limits: 40 years to 55 years.

Want to explore more studies?

Explore studies